Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NATUS MEDICAL INCORPORATED

(NTUS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Natus Medical Incorporated : Secures Inclusion in Government Electronic Catalog

09/27/2021 | 04:51pm EST


© MT Newswires 2021
All news about NATUS MEDICAL INCORPORATED
11/05NATUS MEDICAL INC Management's Discussion and Analysis of Financial Condition and Resu..
AQ
11/04NATUS MEDICAL : Q3 Earnings Snapshot
AQ
11/04Natus Medical Announces Third Quarter 2021 Financial Results - Form 8-K
PU
11/04Natus Medical Posts Higher Q3 Adjusted Earnings, Revenue; Narrows Full-Year Revenue Out..
MT
11/04GUIDANCE : (NTUS) NATUS MEDICAL INCORPORATED Expects Fiscal Year 2021 EPS Range $1.13 - $1..
MT
11/04GUIDANCE : (NTUS) NATUS MEDICAL INCORPORATED Expects Q4 EPS Range $0.41 - $0.46
MT
11/04Earnings Flash (NTUS) NATUS MEDICAL INCORPORATED Reports Q3 EPS $0.28, vs. Street Est o..
MT
11/04Earnings Flash (NTUS) NATUS MEDICAL INCORPORATED Reports Q3 Revenue $113.9M, vs. Street..
MT
11/04Natus Medical Announces Third Quarter 2021 Financial Results
AQ
11/04Natus Medical Incorporated Reports Earnings Results for the Third Quarter and Nine Mont..
CI
More news
Financials (USD)
Sales 2021 471 M - -
Net income 2021 23,8 M - -
Net Debt 2021 - - -
P/E ratio 2021 34,7x
Yield 2021 -
Capitalization 820 M 820 M -
Capi. / Sales 2021 1,74x
Capi. / Sales 2022 1,69x
Nbr of Employees 1 420
Free-Float 98,4%
Chart NATUS MEDICAL INCORPORATED
Duration : Period :
Natus Medical Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NATUS MEDICAL INCORPORATED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 24,29 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Jonathan A. Kennedy President, Chief Executive Officer & Director
Benjamin Drew Davies Chief Financial Officer & Executive Vice President
Joshua H. Levine Non-Executive Chairman
D. Christopher Chung Chief Medical Officer & VP-Regulatory Affairs
Ivan Pandiyan Vice President-Research & Development
Sector and Competitors